The Long COVID Puzzle: Autoimmunity, Inflammation, and Other Possible Causes

It is clear that some groups of people are more vulnerable to developing Long COVID than others, and that may provide important insight into this post-acute infection syndrome’s underlying biology. Women, particularly those in their reproductive years, are more likely to develop Long COVID. Those with type 2 diabetes also seem to have an increased risk for Long COVID. A severe case of COVID-19 is more likely to trigger Long COVID than a milder illness—though it can be present after both forms. And perhaps because of that, people who were unvaccinated at the time of their infection were at higher risk of Long COVID symptoms than those who got the shots, according to research.

As the number of Long COVID cases increases, Iwasaki emphasized how important it is to listen to patients’ accounts of their own experiences. She says that social media and her own personal interactions have brought insight that has led to thinking more about potential treatments, while also demonstrating how harmful disbelief from healthcare providers can be for people with Long COVID.

Elena M. Wilson is an MD/PhD candidate at Yale School of Medicine.

COVID has opened up new areas of interest in medicine. If the COVID-19 pandemic can be said to have done anything good at all, it would have to be the chance to get a better handle on how a simple virus can cause the body to change in ways that last long after the infection is gone. SARS-Co-V2 is only the most recent of the infections that can cause some kind of post-acute infection syndrome.

This is a phenomenon that has been documented after polio, dengue, and chikungunya, as well as after the Epstein-Barr infection and our old friend the flu. But far too often, the souvenirs that these infections leave behind are noted, chins are scratched, and then interest moves on to the next new thing. COVID-19, with its vast reach and egalitarian spirit, has finally provided medicine with a cohort large enough and loud enough to keep our interest. And what’s learned here, in the wake of this virus, is likely to help us with the next infection that leaves a lasting mark on at least some of those it touches.

Read other installments of Long COVID Dispatches here.

If you’d like to share your experience with Long COVID for possible use in a future post (under a pseudonym), write to us at: LongCovidDispatches@yale.edu

Information provided in Yale Medicine content is for general informational purposes only. It should never be used as a substitute for medical advice from your doctor or other qualified clinician. Always seek the individual advice of your health care provider with any questions you have regarding a medical condition.